China's Secret Weapon: The Shocking Drug Supply Chain Vulnerability US Can't Ignore!

Overview

A US report highlights China's tight grip on raw materials essential for medicines, posing a significant supply chain risk. The US-China Economic and Security Review Commission proposes expanding FDA authority to track drug ingredient origins and encourage non-China sourcing, as global reliance on Beijing for key starting materials and active pharmaceutical ingredients reaches critical levels.